Share Prices & Company Research

Stockbroking

Destiny Pharma

Current Price 64.50p Bid 63.00p Ask 66.00p Change 0.78%
Last Updated: 24/11/2020 09:30. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

Financial Highlights Year Ended 31/12/2019

Revenue
£n/am
Operating Profit/Loss
£-5.58m
Dividend yield (%)
n/a
Total dividend for year
n/ap
Dividend cover
n/a
P/E Ratio
n/a

Key Personnel

Mr Shaun Claydon
CFO and Company Secretary
Mr Nick Rodgers
Chairman
Mr Neil Clark
Chief Executive Officer
Dr William Love
Chief Scientific Officer
Mrs Debra Barker
Independent Non-Executive Director
Dr Huaizheng Peng
Non-Executive Director
Mr Peter Morgan
Non-Executive Director

Stock Details

EPIC
DEST
ISIN
GB00BDHSP575
Shares in Issue
43.87m
Market cap
£28.29m

Analyst Views (0)

Strong Buy
 
0%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
64.50p
Bid Price
63.00p
Ask Price
66.00p
Volume
6,631
Change Today
0.50p
% Change Today
0.78%
Open
64.00p
Previous Close
64.00p
Intraday High
64.50p
Intraday Low
63.00p
52 Week High
107.08p
52 Week Low
30.38p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Income Statement

Year End Date
31 Dec 2019
31 Dec 2018
 
£ (M)
£ (M)
Continuing Operations
Revenue
n/a
n/a
Operating Profit/Loss
-5.58
-6.08
Net Interest
0.06
0.08
Pre-Tax Profit
-5.52
-6.01
Profit After Tax from continuing operations
-4.71
-5.17
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
-4.71
-5.17
Attributable to:
Equity Holders of Parent Company
-4.71
-5.17
Minority Interests
n/a
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2019
31 Dec 2018
Basic
-10.66p
-11.85p
Diluted
-10.66p
-11.85p
Adjusted
-10.66p
-11.85p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
0.03
0.03
Intangible Assets
n/a
n/a
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
n/a
n/a
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
1.04
0.97
Cash at Bank & In Hand
7.48
7.06
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
5.00
Other Assets
n/a
n/a
Total Assets
8.56
13.06

Liabilities

Year End Date
31 Dec 2019
31 Dec 2018
 
£ (M)
£ (M)
Current Liabilities
Borrowings
n/a
n/a
Other Current Liabilities
0.80
0.80
Total Current Liabilities
0.80
0.80
Non-Current Liabilities
Borrowings
n/a
n/a
Provisions
n/a
n/a
Other Non-Current Liabilities
n/a
n/a
Total Non-Current Liabilities
n/a
n/a
Other Liabilities
n/a
n/a
Total Liabilities
0.80
0.80

Net Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
£ (M)
£ (M)
Net Assets
7.76
12.26

Capital & Reserves

Year End Date
31 Dec 2019
31 Dec 2018
 
£ (M)
£ (M)
Share Capital
0.44
0.44
Share Premium Account
17.30
17.29
Other Reserves
n/a
n/a
Retained Earnings
-9.98
-5.47
Shareholders Funds
7.76
12.26
Minority Interests/Other Equity
n/a
n/a
Total Equity
7.76
12.26

Dividend History

Dividend Metrics

Year End Date
31 Dec 2019
31 Dec 2018
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.